文献速递炎症性肠病

综述:炎症性肠病的预防——前进之路

Review article: Prevention of inflammatory bowel disease-The path forward.
PubMed 文献 · Aliment Pharmacol Ther · 2024-01-01

本文综述了推进炎症性肠病(IBD)预测与预防领域所需的关键步骤,提出首先应确定最稳健的预测生物标志物并在独立队列中验证以构建多维预测工具,其次需了解IBD患者一级亲属及高危人群的偏好,第三应推动高危门诊建设并建立疾病预防试验网络。

要点

  • 第一步应确定最稳健的预测生物标志物并在独立队列中验证,形成多维预测工具。
  • 第二步需更好地了解IBD一级亲属及高危人群的偏好,以指导筛查与预防策略的实施。
  • 上述工作应促进高危门诊的发展并建立疾病预防试验所需的协作网络。

核心结论

  • 推进IBD预测与预防领域需要多层面的方法,整合生物标志物发现、患者偏好理解以及协作网络的基础设施建设,以支持IBD预防策略的实际实施。

研究设计与样本

  • 综述类文章,检索并回顾当前文献以确定推进IBD预防策略所需的必要步骤。

主要发现

  • 由于对临床前疾病认识的进展以及在其他免疫介导疾病(如1型糖尿病和类风湿关节炎)中预防试验的成功,预防IBD的可能性正变得更加可行。
  • 推进该领域需要在多个方面并行且协调地开展努力。

临床怎么用

  • 第一步应确定最稳健的预测生物标志物并在独立队列中验证,创建多维预测工具。
  • 第二步是更好地了解IBD一级亲属及高危人群的偏好,为筛查和预防策略的实施提供信息。
  • 第三步是这些努力应促进高危门诊的发展并建立疾病预防试验所需的网络。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The possibility of preventing inflammatory bowel disease (IBD) is becoming more plausible due to advances in understanding preclinical disease and successful prevention trials in other immune-mediated diseases, such as type 1 diabetes and rheumatoid arthritis. However, before that possibility becomes reality, several efforts need to occur in parallel and in a coordinated way. AIM: To propose some critical steps necessary for advancing the field of IBD prediction and prevention. METHODS: We reviewed the current literature to identify the necessary steps toward a preventive strategy for IBD. RESULTS: The first step should determine the most robust predictive biomarkers and validate them across independent cohorts, creating a multidimensional predictive tool. The second step is to gain a better understanding of the preferences of first-degree relatives and people at risk for IBD, informing the implementation of screening and preventive strategies. Third, these efforts should contribute to the development of high-risk clinics and establish the necessary networks for disease prevention trials. CONCLUSIONS: Advancing the field of IBD prediction and prevention will require a multifaceted approach, integrating biomarker discovery, understanding patient preferences, and establishing infrastructure for a collaborative network to support the practical implementation of IBD prevention strategies.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Bronze S, Agrawal M, Colombel JF, et al. Review article: Prevention of inflammatory bowel disease-The path forward. Aliment Pharmacol Ther. 2024. PMID: 39403049. doi:10.1111/apt.18263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。